Marije R. Vergeer
VU University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marije R. Vergeer.
International Journal of Radiation Oncology Biology Physics | 2009
Marije R. Vergeer; P. Doornaert; D. Rietveld; C. René Leemans; Ben J. Slotman; Johannes A. Langendijk
PURPOSE The purpose of this study was to compare intensity-modulated radiation therapy (IMRT) and three-dimensional conventional radiotherapy (3D-CRT) with regard to patient-rated xerostomia, Radiation Therapy Oncology Group (RTOG) acute and late xerostomia and health-related quality of life (HRQoL) among patients with head and neck squamous cell carcinoma (HNSCC). METHODS AND MATERIALS Included were 241 patients with HNSCC treated with bilateral irradiation +/- chemotherapy. Since 2000, all patients treated with HNSCC were included in a program, which prospectively assessed acute and late morbidity according to the RTOG and HRQoL on a routine basis at regular intervals. Before October 2004, all patients were treated with 3D-CRT (N = 150). After clinical implementation in October 2004, 91 patients received IMRT. In this study, the differences regarding RTOG toxicity, xerostomia, and other items of HRQoL were analyzed. RESULTS The use of IMRT resulted in a significant reduction of the mean dose of the parotid glands (27 Gy vs. 43 Gy (p < 0.001). During radiation, Grade 2 RTOG xerostomia was significantly less with IMRT than with 3D-CRT. At 6 months, the prevalence of patient-rated moderate to severe xerostomia and Grade 2 or higher RTOG xerostomia was significantly lower after IMRT versus 3D-CRT. Treatment with IMRT also had a positive effect on several general and head and neck cancer-specific HRQoL dimensions. CONCLUSIONS IMRT results in a significant reduction of patient- and observer-rated xerostomia, as well as other head and neck symptoms, compared with standard 3D-CRT. These differences translate into a significant improvement of the more general dimensions of HRQoL.
International Journal of Radiation Oncology Biology Physics | 2010
Marije R. Vergeer; P. Doornaert; Anja Jonkman; Johannes H.A.M. Kaanders; Piet van den Ende; Martin A. de Jong; C. René Leemans; Ben J. Slotman; Johannes A. Langendijk
PURPOSE The purpose was to evaluate the contralateral nodal control (CLNC) in postoperative patients with oral and oropharyngeal cancer treated with ipsilateral irradiation of the neck and primary site. Late radiation-induced morbidity was also evaluated. METHODS AND MATERIALS The study included 123 patients with well-lateralized squamous cell carcinomas treated with surgery and unilateral postoperative irradiation. Most patients had tumors of the gingiva (41%) or buccal mucosa (21%). The majority of patients underwent surgery of the ipsilateral neck (n = 102 [83%]). The N classification was N0 in 73 cases (59%), N1 or N2a in 23 (19%), and N2b in 27 cases (22%). RESULTS Contralateral metastases developed in 7 patients (6%). The 5-year actuarial CLNC was 92%. The number of lymph node metastases was the only significant prognostic factor with regard to CLNC. The 5-year CLNC was 99% in N0 cases, 88% in N1 or N2a cases, and 73% in N2b cases (p = 0.008). Borderline significance (p = 0.06) was found for extranodal spread. Successful salvage could be performed in 71% of patients with contralateral metastases. The prevalence of Grade 2 or higher xerostomia was 2.6% at 5 years. CONCLUSIONS Selected patients with oral or oropharyngeal carcinoma treated with primary surgery and postoperative ipsilateral radiotherapy have a very high CLNC with a high probability of successful salvage in case of contralateral metastases. However, bilateral irradiation should be applied in case of multiple lymph node metastases in the ipsilateral neck, particularly in the presence of extranodal spread. The incidence of radiation-induced morbidity is considerably lower as observed after bilateral irradiation.
Annals of Oncology | 2011
Marije R. Vergeer; P. Doornaert; R. de Bree; C.R. Leemans; B.J. Slotman; Johannes A. Langendijk
BACKGROUND This study describes the results of elective irradiation in the N0 neck and tries to identify prognostic factors for regional recurrence. MATERIALS AND METHODS Between 1985 and 2000, 785 cN0 or pN0 necks were treated with elective nodal irradiation in 619 head and neck squamous cell carcinoma patients. RESULTS Regional control at 3 years was 94% in the cN0 (nondissected) neck compared with 97% in the pN0 (dissected) neck and 90% in the ipsilateral compared with 96% in the contralateral neck (P = 0.08 and P = 0.006, respectively). Regional control in the ipsilateral cN0 neck was 78% compared with 96% in the contralateral cN0 neck. Surgical margin of the primary tumor was an additional prognostic factor in all N0 and pN0 necks. CONCLUSIONS Neck control rates in electively irradiated N0 necks were excellent. Regional control was worse in the cN0 neck compared with the pN0 neck and in the ipsilateral neck compared with the contralateral side. Additionally, in case of positive surgical margins of the primary tumor, elective nodal irradiation should be applied, even in case of a pN0 neck.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2017
Stijn van Weert; Rinze Reinhard; Elisabeth Bloemena; Jan Buter; Birgit I. Witte; Marije R. Vergeer; C. René Leemans
We examined the assumption in conventional teaching about metastatic adenoid cystic carcinoma (ACC) being an indolent type of disease.
Radiotherapy and Oncology | 2006
Marije R. Vergeer; P. Doornaert; C. René Leemans; Jan Buter; Ben J. Slotman; Johannes A. Langendijk
BMC Cancer | 2017
Sven van den Bosch; T. Dijkema; Martina C. Kunze-Busch; Chris H.J. Terhaard; Cornelis P.J. Raaijmakers; P. Doornaert; Frank Hoebers; Marije R. Vergeer; Bas Kreike; Oda B. Wijers; Wim J.G. Oyen; Johannes H.A.M. Kaanders
Radiotherapy and Oncology | 2017
Johannes H.A.M. Kaanders; W. Bots; C. Terhaard; Marije R. Vergeer; P. Doornaert; H.P. Bijl; P. van den Ende; M. de Jong; Geert O. Janssens; Paul N. Span
Radiotherapy and Oncology | 2012
Marije R. Vergeer; P. Doornaert; D. Rietveld; C.R. Leemans; J.A. Langendijk; B.J. Slotman
Archive | 2010
Marije R. Vergeer; P. Doornaert; Anja Jonkman; Johannes H.A.M. Kaanders; Piet van den Ende; Martin de Jong; C. René Leemans; Ben J. Slotman; Johannes A. Langendijk
Radiotherapy and Oncology | 2007
Marije R. Vergeer; P. Doornaert; D. Rietveld; A. P. Jellema; C.R. Leemans; B.J. Slotman; Johannes A. Langendijk